FDA Inspection 985869 — New York Blood Center Enterprises
The FDA completed an inspection of New York Blood Center Enterprises on August 22, 2016 in Rye, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- August 22, 2016
- Fiscal Year
- 2016
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Rye, NY (United States)